Telomerase activation by human papillomavirus type 16 E6 protein: Induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites

Journal of Virology

Volumn 75, Issue 12, 2001, Pages 5559-5566

  Oh, Stephen T ^a   Kyo, Saturo ^b   Laimins, Laimonis A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; KERATINOCYTE; ONCOGENE MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROCESSING; WART VIRUS;

BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; RNA; SP1 TRANSCRIPTION FACTOR; TELOMERASE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0035000951     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.12.5559-5566.2001     Document Type: Article

References (39)

1. Bodnar, A. G., M. Ouellette, M. Frolkis, S. E. Holt, C. P. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner, and W. E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
2. Cannistra, S. A., and J. M. Niloff. 1996. Cancer of the uterine cervix. N. Engl. J. Med. 334:1030-1038.
3. Colgin, L. M., and R. R. Reddel. 1999 Telomere maintenance mechanisms and cellular immortalization. Curr Opin. Genet. Dev. 9:97-103. (Erratum, 9:247.)
4. Desaintes, C., S. Hallez, P. Van Alphen, and A. Burny. 1992. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J. Virol. 66:325-333.
5. de Villiers, E. M. 1994. Human pathogenic papillomavirus types: an update. Curr. Top. Microbiol. Immunol. 186:1-12.
6. Dey, A., I. A. Atcha, and S. Bagchi. 1997. HPV16 E6 oncoprotein stimulates the transforming growth factor-beta 1 promoter in fibroblasts through a specific GC-rich sequence. Virology 228:190-199.
7. INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20:1436-1447.
8. Dyson, N., P. M. Howley, K. Münger, and E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
9. Greenberg, R. A., R. C. O'Hagan, H. Deng, Q. Xiao, S. R. Hann, R. R. Adams, S. Lichtsteiner, L. Chin, G. B. Morin, and R. A. DePinho. 1999. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18:1219-1226.
10. Gross-Mesilaty, S., E. Reinstein, B. Bercovich, K. E. Tobias, A. L. Schwartz, C. Kahana, and A. Ciechanover. 1998. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc. Natl. Acad. Sci. USA 95:8058-8063.
11. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473-478.
12. Hawley-Nelson, P., K. H. Vousden, N. L. Hubbert, D. R. Lowy, and J. T. Schiller. 1989. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:3905-3910.
13. Howley, P. M. 1996. Papillomavirinae: the viruses and their replication, p. 947-978. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fundamental virology. Lippincott-Raven, Philadelphia, Pa.
14. Hudson, J. B., M. A. Bedell, D. J. McCance, and L. A. Laimins. 1990. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol. 64:519-526.
15. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus type 16 or 18. EMBO J. 10:4129-4135.
16. Jones, D. L., and K. Münger. 1996. Interactions of the human papillomavirus E7 protein with cell cycle regulators. Semin. Cancer Biol. 7:327-337.
17. Kinoshita, T., H. Shirasawa, Y. Shino, H. Moriya, L. Desbarats, M. Eilers, and B. Simizu. 1997. Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein. Virology 232:53-61.
18. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88.
19. Klingelhutz, A. J., S. A. Foster, and J. K. McDougall. 1996. Telomerase activation hy the E6 gene product of human papillomavirus type 16. Nature 380:79-82.
20. Kyo, S., M. Takakura, T. Taira, T. Kanaya, H. Itoh, M. Yutsudo, H. Ariga, and M. Inoue. 2000. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 28:669-677.
21. Laimins, L. A. 1993. The biology of human papillomaviruses: from warts to cancer. Infect. Agents Dis. 2:74-86.
22. Lechner, S. M., D. H. Mack, A. B. Finicle, T. Crook, K. H. Vousden, and L. A. Laimins. 1992. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11:3045-3052. (Erratum, 11:4248.)
23. Liu, J. P. 1999. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 13:2091-2104.
24. Mallon, R. G., D. Wojciechowicz, and V. Defendi. 1987. DNA-binding activity of papillomavirus proteins. J. Virol. 61:1655-1660.
25. Mantovani, F., and L. Banks. 1999. The interaction between p53 and papillomaviruses. Semin. Cancer Biol. 9:387-395.
26. Meyers, C., and L. A. Laimins. 1994. In vitro systems for the study and propagation of human papillomaviruses. Curr. Top. Microbiol. Immunol. 186:199-215.
27. Morosov, A., W. C. Phelps, and P. Raychaudhuri. 1994. Activation of the c-fos gene by the HPV16 oncoproteins depends upon the cAMP-response element at -60. J. Biol. Chem. 269:18434-18440.
28. Münger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
29. Münger, K., B. A. Werness, N. Dyson, W. C. Phelps, E. Harlow, and P. M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8:4099-4105.
30. Nugent, C. I., and V. Lundblad. 1998. The telomerase reverse transcriptase: components and regulation. Genes Dev, 12:1073-1085.
31. Philipsen, S., and G. Suske. 1999. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 27:2991-3000.
32. Scheffner, M., J. M. Huibregtse, R. D. Vierstra, and P. M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
33. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
34. Suske, G. 1999. The Sp-family of transcription factors. Gene 238:291-300.
35. Thomas, J. T., and L. A. Laimins. 1998. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J. Virol. 72:1131-1137.
36. Wang, J., L. Y. Xie, S. Allan, D. Beach, and G. J. Hannon. 1998. Myc activates telomerase. Genes Dev. 12:1769-1774.
37. Werness, B. A., A. J. Levine, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
38. Wu, K. J., C. Grandori, M. Amacker, N. Simon-Vermot, A. Polack, J. Lingner, and R. Dalla-Favera. 1999. Direct activation of TERT transcription by C-MYC. Nat. Genet. 21:220-224.
39. zur Hausen, H. 2000. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:690-698.